Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
3.110
-0.310 (-9.06%)
Nov 20, 2026, 4:00 PM EST - Market closed
Immutep Market Cap
Immutep has a market cap or net worth of $23.5 million as of November 20, 2026. Its market cap has decreased by 90.59% in one year.
Market Cap
23.50M
Enterprise Value
-21.56M
1-Year Change
-90.59%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since April 19, 2012, Immutep's market cap has decreased from $74.60M to $23.50M, a decrease of -68.50%. That is a compound annual growth rate of -7.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 22.90M | -94.52% |
| Dec 31, 2025 | 417.70M | 32.52% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
| Apr 19, 2012 | 74.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 29.39M |
| Alterity Therapeutics | 29.20M |
| ProMIS Neurosciences | 28.79M |
| Filana Therapeutics | 28.15M |
| INmune Bio | 27.68M |
| Pelthos Therapeutics | 27.48M |
| BriaCell Therapeutics | 27.33M |
| Adicet Bio | 26.48M |